Meaningful use Stage 2 requirements are accelerating EMR-specific patient portal adoption at an increasing rate. The latest KLAS report, entitled Patient Portals 2013: On Track for Meaningful Use?, finds that this increase is having a negative effect on best-of-breed vendors, as providers report that third-party solutions are not as well equipped as EMR offerings for the more engaging requirements of MU Stage 2.
The report showcases the performance of each of the patient portal offerings in the face of MU Stage 2 criteria, including patient engagement, ease of use, and support. The report also captures provider feedback on both the current states of the products and areas of future growth.
“The HITECH Act that launched MU Stage 2 is clearly aiding the EMR vendors in this segment,” said report author and research director Mark Allphin. “However, there are advantages to looking outside your EMR. Many providers are still trying to determine which portal solution will best meet their needs, now and in the future as they continue to engage their patients on a deeper level.”
As part of the study, KLAS spoke with over 200 providers about their patient portals. KLAS collected data on Allscripts (Jardogs), athenahealth, Cerner, eClinicalWorks, Epic, Greenway Medical, Intuit Health, NextGen, and Vitera.
For further details, visit KLAS online at www.KLASresearch.com/reports and view Patient Portals 2013: On Track for Meaningful Use? The report is available to healthcare providers and vendors. Providers receive a significant discount off the standard retail price or can receive a complimentary summary report in exchange for a survey about one of their current vendors.